BOUT

Fund Description
The Innovator IBD Breakout Opportunities ETF seeks to provide exposure to the investment results of the IBD Breakout Stocks Index. The Index leverages decades of Investors Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience a period of sustained price growth beyond the securitys recent "resistance level", with consideration for various market conditions.
Fund Profile
Fund Name Innovator IBD Breakout Opportunities ETF
Fund Exchange Ticker BOUT
Fund Sponsor Innovator Management
Fund ISIN US45782C7636
Net Expense Ratio 0.80 %
Fund Inception Date 13 September 2018
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Factor & Thematic
Asset Class Equities (Stocks)
Index Linked Passive
Index Name IBD Breakout Stocks Index
Index Provider IBD
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 22 January 2019
Asset Under Management 10.25 Million (USD)
1 Month Total Return 5.08 %
Year To Date Return 6.82 %
1 Year Total Return
3 Year Annualized Total Return
NAV 18.64
Share Outstanding 550,000
Top 10 Holdings (22 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
ANAPLAN INC PLAN EQUI 0.0253000000
GLOBAL PAYMENTS INC GPN EQUI 0.0253000000
AUTODESK INC ADSK EQUI 0.0253000000
FIDELITY NATIONAL INFO SERV FIS EQUI 0.0253000000
Bain Capital Specialty Finance BCSF EQUI 0.0252000000
MCDONALD'S CORP MCD EQUI 0.0250000000
WRIGHT MEDICAL GROUP NV WMGI EQUI 0.0249000000
LENNOX INTERNATIONAL INC LII EQUI 0.0248000000
GRACO INC GGG EQUI 0.0247000000
EXACT SCIENCES CORP EXAS EQUI 0.0247000000